| [1] |
ZHANG Wentao, LIU Yongqiang, WU Yang, CHEN Haotian, GUO Yadong, ZHANG Junfeng, MAO Shiyu, SHEN Liliang, MA Wenchao, WANG Ruiliang, XU Tianyuan, GENG Jiang, SHEN .
Research progress on targets for antibody⁃drug conjugate in urothelial carcinoma: clinical value and future challenges of NECTIN⁃4,HER⁃2,and TROP⁃2
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(6): 672-682.
|
| [2] |
ZHOU Jing, LI Jun, LI Hui, LI Min.
Clinicopathological analysis of duodenal-type follicular lymphoma and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 598-603.
|
| [3] |
WANG Wei, ZHAO Jiahui, CUI Jiayuan, HONG Bao'an, LYU Qiang, WANG Sheng, CHEN Chen, LI Quan, ZHANG Jingrui, CHU Huijun, ZHANG Xuezhou, WANG Yuxuan, SUN Zhipeng, BO Yuxuan, MIAO Qi, TANG Yibo, ZHANG Ning.
Perioperative safety management strategies and clinical outcomes in patients with renal cell carcinoma complicated by heart failure
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 541-547.
|
| [4] |
LIANG Zhuowei, DU Youqin, YAN Chang, YANG Xiaohui, HUANG Shiting, QU Song.
Comparative efficacy and safety of TPF versus GP induction chemotherapy combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 366-371.
|
| [5] |
WANG Shenghui, ZHANG Zongnai , JIA Zhichao, ZHENG Bin, LI Xiaoyu , GAO Yuan , ZHOU Mai.
CRS combined with HIPEC for peritoneal metastasis in colorectal cancer: correlation between primary tumor location and clinical outcomes
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(2): 195-200.
|
| [6] |
ZHANG Yuanfen, LONG Ying, YAO Desheng.
Relationship between perineural invasion,clinical pathological characteristics of cervical cancer and its effects on prognosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 109-114.
|
| [7] |
CHEN Kun, YANG Hui, LIU Zijia, ZHANG Xiaolin, XU Zhuoyi, LIU Bing, ZHAO Yubao, DING Lu, DENG Yang.
Expression of HLA-DRA protein in hepatocellular carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 84-89.
|
| [8] |
ZHU Lin, LU Ning, YANG Lin, WEN Hua, CUI Manli, ZHANG Mingxin.
The clinical value of inflammatory burden index in the diagnosis and prognosis of colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 543-548.
|
| [9] |
QIN Shuiling, XU Jingxuan, WEI Haowen, MA Liang, QI Lunan.
Prognostic value of ADH1B in patients with hepatocellular carcinoma with vascular invasion and its effect on the biological behavior of liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 383-390.
|
| [10] |
ZHAO Guangqiang, XUE Tianhui, YAN Bing .
The value of the ratio of pre-operative platelet distribution width to tumor size in the prognosis of patients with non-metastatic lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 317-321.
|
| [11] |
ZHANG Haoting, YANG Yintao, MA Yujie, LI Jinglei, YANG Haozhi, LI Zhou, WANG Shuo.
Expression of cytoskeleton associated protein 4 in clear cell renal cell carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 190-195.
|
| [12] |
QUAN Xiaoying, WU Chunzhi, CHEN Xiaoyan, LEI Lei, YE Bin, ZHANG Zhihui.
Clinical efficacy of P-Gemox regimen combined intensity-modulated radiation therapy treatment for early-stage extranodal NK/T cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 75-80.
|
| [13] |
LIAO Bin,YANG Zhan-bin.
Expression and clinical significance of EZH2,FHIT and VEGF in bladder urothelial car-cinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(2): 142-144.
|